Facts about Nycomed Canada
Learn more about Nycomed Canada by reading our fact sheet.
Latest News
09.09.09
Four studies published in The Lancet show roflumilast (Daxas), a new oral approach to COPD, improves lung function and reduces exacerbations
Lancet Canadian Press Release ...
24.04.09
Nycomed’s Instanyl® receives positive CHMP opinion, bringing forward a new treatment for breakthrough cancer pain

Nycomed's Instanyl® receives positive CHMP opinion, bringing forward a new treatment for breakthrough cancer pain ...
07.04.09
Distribution Agreement for Pollinex® R in Canada Exclusive Negotiation Period for Pollinex Quattro in Canada
Press Release Distribution Agreement for Pollinex® R in Canada Exclusive Negotiation Period for Pollinex Quattro in Canada ...
Media
Information available to the media and public in this section includes, Current Releases and Archived Releases, as well as a Nycomed Canada Fact Sheet. 

Members of the media who wish to contact Nycomed for information, may do so by calling (905) 469-9333 or toll free at 1 (888) 367-3331, or by email at canadian.communications@nycomed.com.


Corporate Media
Find Nycomed’s corporate press releases, publications, financial reports and upcoming events.


Disclaimer